This inventor holds 1 USPTO granted patent. Top assignee: Richter Gedeon Vegyeszeti Gyar Rt. Active years: 1986.
Company Filing History:
Years Active: 1986
Title: Oszkar Fuchs: Innovator in Pharmaceutical Chemistry
Introduction
Oszkar Fuchs is a notable inventor based in Dunakeszi, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on cimetidine monohydrate. His research has implications for the treatment of various medical conditions, showcasing the importance of innovation in healthcare.
Latest Patents
Oszkar Fuchs holds a patent for a new monohydrate of N-methyl-N'-{2-[(5-methylimidazol-4-yl)-methylthio]-ethyl}-N'-cyanoguanidine, commonly known as cimetidine. This compound acts as a histamine-H2 receptor antagonist. The patent details a process for preparing this monohydrate, which involves pouring a hot, homogeneous aqueous solution of the compound onto ice and subsequently separating the cimetidine monohydrate.
Career Highlights
Fuchs is associated with Richter Gedeon Vegyeszeti Gyar Rt, a prominent pharmaceutical company. His work has contributed to advancements in drug formulation and delivery, enhancing the efficacy of treatments available to patients. With a total of 1 patent, his contributions are recognized within the scientific community.
Collaborations
Throughout his career, Oszkar Fuchs has collaborated with esteemed colleagues such as Ferenc Morasz and Eva Againe Csongor. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Oszkar Fuchs exemplifies the spirit of innovation in the pharmaceutical industry. His work on cimetidine monohydrate highlights the critical role of inventors in advancing medical science. Through his contributions, he continues to impact the field positively.